Dr. Farida Al Hosani, Official Spokesperson of the UAE Health Sector, stated that National Vaccination Campaign in the UAE continues to achieve its goals, with over 72.03 percent of the eligible criteria of the population (people over 16 years), and 79.03 percent of those over 60 years having been vaccinated.
She said that the UAE has provided over 11 million doses of the vaccine, at a rate of 113.10 doses for every 100 persons, while the number of COVID-19 tests carried out in the country exceeded 46 million. ”This makes the UAE one of the world’s most efficient examples in managing and curing the spread of the virus.” Dr. Al Hosani stressed that the country’s health authorities are closely monitoring the efficiency of vaccines, by observing the developments of clinical trials and their effectiveness in the community and tracking positive cases registered in the country.
RELATED STORY: UAE starts distribution of locally-made Hayat-Vax COVID-19 vaccine
Last week, the Sinopharm vaccine has been approved by the World Health Organisation (WHO) after reviewing studies on its safety and efficiency, and the UAE provided data that supported this decision, she noted.
“On this occasion, we would like to thank the field employees and volunteers of clinical trials for their distinguished efforts to reach the final approval,” she added.
She then pointed out that the UAE was among the first countries to use the vaccine after its local assessment, and the vaccine has been proven efficient and safe and offers numerous other advantages, including easy transportation and storage.
READ ON:Vaccines available in UAE among the best globally: Farida Al Hosani
Dr. Al Hosani further added that the vaccine is produced in the conventional way and utilises an inactive virus like most vaccines for other diseases, offering greater safety and protection from serious complications.
She also revealed that a study conducted on the efficiency of the national vaccination campaign, has shown that non-vaccinated persons are most vulnerable to severe complications caused by COVID-19, “so everyone should take the vaccine.”
During the UAE Government media briefing on the pandemic today, Dr. Al Hosani stressed that the study’s findings highlighted a significant decline in infection rates after being vaccinated by the second dose.
The study also revealed that the vaccine’s efficiency in preventing people from being hospitalised amounted to 93 percent, while its efficiency in preventing them from being admitted to an intensive care unit (ICU) is 95 percent.
